Skip to main content

Table 2 Tumour characteristics

From: Complications of intravesical BCG therapy in non-muscle invasive bladder cancer: our tertiary care centre experience

Tumour characteristics Number of patients (N = 149)
Tumour presentation
 Primary 127 (85.23%)
 Recurrent 22 (14.76%)
Number of the tumour
 Single 97 (65.1%)
 Multiple 52 (34.8%)
Size of the tumour
 < 3 cm 104 (69.79%)
 > 3 cm 45 (30.2%)
T stage after first TURBT
 T0 11
 Ta low grade 19
 Ta high grade 50
 T1 44
 CIS 25
T stage after second TURBT
 T0 51
 Ta low grade 09
 Ta high grade 24
 T1 18
 CIS 21
 Biopsy not required 26
Planned BCG course
 1 year 105 (70.4%)
 3 year 44 (29.5%)
Course completed 96 (64.4%)
Course interrupted 53 (35.5%)